What exact chemical components are in Apotex’s ruxolitinib formulation?
The provided information does not list or describe the new chemical components in Apotex’s ruxolitinib formulation. Without the specific label/manufacturer documentation (for example, the product’s prescribing information, Canadian DIN/Health Canada product monograph, or the composition section from the relevant filing), I can’t accurately identify which ingredients Apotex added or changed.
Where to find the “components” list for ruxolitinib tablets (to identify what’s new)
To specify the chemical components, you typically need the “Composition” section from the official product documentation for the exact Apotex ruxolitinib product (strength, dosage form, and market). That section usually enumerates:
- Active ingredient (ruxolitinib)
- Excipients (binders, fillers, disintegrants, coatings, colorants, etc.)
- Any formulation-specific differences (e.g., film coat composition, tablet core ingredients)
How to compare “new” components vs an older formula
If your goal is to find what Apotex changed, you’d compare excipient lists between:
- The earlier Apotex ruxolitinib filing/product version and
- The newer Apotex ruxolitinib version you’re referring to
Even small wording changes (e.g., “microcrystalline cellulose” variants, different film-coat materials, or different colorants/dyes) can indicate new components, but the only reliable way is side-by-side comparison of the official composition tables.
If you share the document, I can extract the components precisely
Paste the “Composition/Excipients” section (or link the product monograph/DIN page) for Apotex’s ruxolitinib formulation you mean, and I’ll extract the exact chemical components and flag which ones appear to be newly added or different.
Sources
No sources were provided in your prompt, so I can’t cite any composition details.